CN102757912A - Salmonella typhimurium X3337lux and applications of salmonella typhimurium X3337lux in living body imaging - Google Patents
Salmonella typhimurium X3337lux and applications of salmonella typhimurium X3337lux in living body imaging Download PDFInfo
- Publication number
- CN102757912A CN102757912A CN2012102062501A CN201210206250A CN102757912A CN 102757912 A CN102757912 A CN 102757912A CN 2012102062501 A CN2012102062501 A CN 2012102062501A CN 201210206250 A CN201210206250 A CN 201210206250A CN 102757912 A CN102757912 A CN 102757912A
- Authority
- CN
- China
- Prior art keywords
- salmonella typhimurium
- x3337lux
- bacteria
- researching
- bacterial strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 title claims abstract description 41
- 238000003384 imaging method Methods 0.000 title abstract description 11
- 238000004321 preservation Methods 0.000 claims abstract description 9
- 238000009629 microbiological culture Methods 0.000 claims abstract 2
- 238000010859 live-cell imaging Methods 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 abstract description 28
- 230000001580 bacterial effect Effects 0.000 abstract description 21
- 239000013612 plasmid Substances 0.000 abstract description 19
- 238000004020 luminiscence type Methods 0.000 abstract description 17
- 238000005415 bioluminescence Methods 0.000 abstract description 13
- 230000029918 bioluminescence Effects 0.000 abstract description 13
- 238000001727 in vivo Methods 0.000 abstract description 10
- 208000015181 infectious disease Diseases 0.000 abstract description 8
- 238000001514 detection method Methods 0.000 abstract description 7
- 238000012216 screening Methods 0.000 abstract description 7
- 230000005284 excitation Effects 0.000 abstract description 5
- 230000003950 pathogenic mechanism Effects 0.000 abstract description 5
- 230000007547 defect Effects 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 238000002474 experimental method Methods 0.000 abstract description 2
- 238000000338 in vitro Methods 0.000 abstract description 2
- 230000008030 elimination Effects 0.000 abstract 1
- 238000003379 elimination reaction Methods 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 17
- 241000699670 Mus sp. Species 0.000 description 12
- 239000007788 liquid Substances 0.000 description 12
- 241001465754 Metazoa Species 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- 238000003390 bioluminescence detection Methods 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 108060001084 Luciferase Proteins 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 239000005089 Luciferase Substances 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 244000052616 bacterial pathogen Species 0.000 description 5
- 230000001018 virulence Effects 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 3
- 108700039887 Essential Genes Proteins 0.000 description 3
- 210000003578 bacterial chromosome Anatomy 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000011503 in vivo imaging Methods 0.000 description 3
- 239000007928 intraperitoneal injection Substances 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 230000006798 recombination Effects 0.000 description 3
- 238000005215 recombination Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 2
- 239000006142 Luria-Bertani Agar Substances 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000000799 fluorescence microscopy Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000000504 luminescence detection Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 108090000363 Bacterial Luciferases Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241001138501 Salmonella enterica Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011217 control strategy Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 108091008053 gene clusters Proteins 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 238000012634 optical imaging Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 101150084425 spvB gene Proteins 0.000 description 1
- 101150022709 spvC gene Proteins 0.000 description 1
- 230000010473 stable expression Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
the
技术领域 technical field
本发明属于微生物技术领域,特别涉及鼠伤寒沙门菌X3337lux及其在活体成像中的应用。 The invention belongs to the technical field of microorganisms, in particular to Salmonella typhimurium X3337lux and its application in live imaging.
the
背景技术 Background technique
鼠伤寒沙门菌(Salmonella typhimurium) 宿主范围广泛可造成人和动物的多种疾病,开展其致病机制的研究具有重要的现实意义。质粒是细菌染色体以外的遗传物质,包含许多重要的基因簇,与细菌的共生、代谢、致病机制密切相关。鼠伤寒沙门菌Χ3337是毒力质粒消除后的菌株,可作为对照用于研究鼠伤寒沙门菌毒力质粒的功能。 Salmonella typhimurium ( Salmonella typhimurium ) has a wide range of hosts and can cause many diseases in humans and animals. It is of great practical significance to study its pathogenic mechanism. Plasmid is the genetic material outside the bacterial chromosome, which contains many important gene clusters, and is closely related to the symbiosis, metabolism and pathogenic mechanism of bacteria. Salmonella typhimurium X3337 is a strain after eliminating the virulence plasmid, which can be used as a control to study the function of the virulence plasmid of Salmonella typhimurium.
近年来,活体动物体内光学成像技术以其操作简便及直观性在生命科学研究中得以不断发展。这种成像技术可以直接实时观察标记的基因及细胞在活体动物体内的活动及反应。生物发光技术(bioluminescence)是目前活体成像研究的热点,它是用荧光素酶(luciferase)基因标记。以荧光素酶作为体内报告源的生物发光是以酶和底物的特异作用而发光,特异性极强,因动物本身没有任何自发光,使得生物发光具有极低的背景,极高的信噪比。生物发光成像相对于传统的荧光成像最大的特点就是体内检测的高灵敏度。荧光成像法在受到激发光激发时,生物体很多物质(如皮肤、毛发和各种组织及食物等)都会产生荧光。特别是当被标记的靶点深藏于组织内部、需要较高能量的激发光时,也产生很强的非特异性荧光。这些非特异性荧光产生的背景噪音使其信噪比远远低于生物发光。另外,荧光发光的信号水平取决于激发光的强度、发光细胞的数量、靶点的深度、光线穿过的组织对其的吸收及散射等因素,使得荧光强度很难定量。而生物发光技术可弥补其不足。 In recent years, in vivo optical imaging technology of living animals has been continuously developed in life science research due to its simple operation and intuitiveness. This imaging technology can directly observe the activities and responses of the marked genes and cells in living animals in real time. Bioluminescence technology (bioluminescence) is currently a hot spot in vivo imaging research, which is marked with luciferase (luciferase) gene. The bioluminescence using luciferase as the reporter source in the body emits light through the specific interaction between the enzyme and the substrate, and the specificity is extremely strong. Because the animal itself does not have any self-luminescence, the bioluminescence has extremely low background and high signal-to-noise Compare. Compared with traditional fluorescence imaging, the biggest feature of bioluminescent imaging is the high sensitivity of in vivo detection. When the fluorescence imaging method is excited by the excitation light, many substances in the organism (such as skin, hair, various tissues and food, etc.) will produce fluorescence. Especially when the marked target is hidden deep inside the tissue and requires higher energy excitation light, it also produces strong non-specific fluorescence. The background noise generated by these non-specific fluorescence makes the signal-to-noise ratio much lower than that of bioluminescence. In addition, the signal level of fluorescence depends on factors such as the intensity of excitation light, the number of luminescent cells, the depth of the target, the absorption and scattering of the tissue through which the light passes, making it difficult to quantify the fluorescence intensity. Bioluminescent technology can make up for its shortcomings.
细菌荧光素酶基因操纵子LuxCDABE由荧光素酶基因和其底物合成酶基因组成,其标记的细菌会持续发光不需要外源性底物。近年来研究者们陆续将其克隆至多种载体导入病原菌中,应用生物发光技术和小动物成像系统监测病原菌感染过程。但以质粒为基础的生物发光技术在无抗生素选择下不稳定,不能用于体内的长期研究。对实验小鼠注射抗生素来筛选携带完整发光质粒的沙门菌,会造成小鼠的耐药性,且会在某种程度上干扰实验结果。又因质粒的拷贝数不同,单细胞发光强度不稳定,无法以发光强度来定量检测病原菌。2010年,Kevin Howe构建质粒pBEN276,利用该质粒可将Lux操纵子克隆至细菌染色体(图1),其生物发光信号可以用于精确定量,本发明由此在鼠伤寒沙门菌X3337基础上构建了具有稳定生物发光性能的菌株X3337lux。利用发光菌X3337lux作为对照建立动物模型,可以实时动态追踪细菌在动物活体内的播散过程,深入研究病原菌的致病机制,进行药物研究及筛选等。 Bacterial luciferase gene operon Lux CDABE is composed of luciferase gene and its substrate synthase gene, and the bacteria marked by it will continue to emit light without exogenous substrates. In recent years, researchers have successively cloned it into various vectors and introduced it into pathogenic bacteria, and applied bioluminescence technology and small animal imaging system to monitor the infection process of pathogenic bacteria. But plasmid-based bioluminescence is unstable without antibiotic selection and cannot be used for long-term studies in vivo. Injecting antibiotics into experimental mice to screen for Salmonella carrying intact luminescent plasmids will cause drug resistance in mice and interfere with experimental results to some extent. Due to the different copy numbers of the plasmids, the luminescence intensity of single cells is not stable, so it is impossible to quantitatively detect pathogenic bacteria by luminescence intensity. In 2010, Kevin Howe constructed the plasmid pBEN276, which can be used to clone the Lux operon into the bacterial chromosome (Figure 1), and its bioluminescent signal can be used for accurate quantification. Therefore, the present invention is constructed on the basis of Salmonella typhimurium X3337 Strain X3337lux with stable bioluminescent properties. Using the luminescent bacterium X3337lux as a control to establish an animal model, it is possible to dynamically track the dissemination process of bacteria in living animals in real time, in-depth study of the pathogenic mechanism of pathogenic bacteria, and drug research and screening.
the
发明内容 Contents of the invention
解决的技术问题:Technical issues solved:
本发明针对荧光标记的体内检测特异性低,背景高,难定量等缺陷,及以往以基于质粒的生物发光检测需外加筛选压力和底物,且难以定量等不足,提供了一种可以稳定发光的鼠伤寒沙门菌X3337lux及其在活体成像中的应用。 The present invention aims at the defects of low specificity, high background, and difficult quantification of fluorescent markers in vivo detection, and the shortcomings of conventional plasmid-based bioluminescence detection that require additional screening pressure and substrates, and are difficult to quantify, etc., and provides a stable luminescence Salmonella typhimurium X3337lux and its use in intravital imaging.
技术方案:Technical solutions:
鼠伤寒沙门菌(Salmonella typhimurium) X3337lux,该菌株已在国家知识产 权局指定的保藏单位保藏,保藏日期为2012年3月13日,保藏单位名称:中国微生物菌种保藏管理委员会普通微生物中心,保藏编号:CGMCC No.5894。鼠伤寒沙门菌(Salmonella typhimurium) X3337lux在活体成像中的应用。 Salmonella typhimurium ( Salmonella typhimurium ) X3337lux, the strain has been preserved in the preservation unit designated by the State Intellectual Property Office, the preservation date is March 13, 2012, the name of the preservation unit: China Microorganism Culture Collection Management Committee General Microbiology Center, deposit Number: CGMCC No.5894. Application of Salmonella typhimurium ( Salmonella typhimurium ) X3337lux in live imaging.
鼠伤寒沙门菌(Salmonella typhimurium)X3337下文简称X3337;鼠伤寒沙门菌(Salmonella typhimurium) X3337lux下文简称X3337lux。 Salmonella typhimurium ( Salmonella typhimurium ) X3337 is hereinafter referred to as X3337; Salmonella typhimurium ( Salmonella typhimurium ) X3337lux is hereinafter referred to as X3337lux.
有益效果:该鼠伤寒沙门菌具有稳定的生物发光性能,弥补了生物荧光的细菌检测需激发光源且在体内特异性低,背景高,难定量等缺陷。经位点特异性重组,将管家基因E.coli frr启动子和Lux操纵子插入宿主菌染色体中稳定表达(同时插入位点不破坏基因组基因功能,对细菌无不利影响)。Lux操纵子在其上游连接的管家基因E.coli frr启动子的调控下,组成性表达荧光素酶和底物,无需外加筛选压力和底物维持细菌发光。并通过实验检测到细菌的数量与其发光强度成正比,且在小鼠活体内能持续检测到细菌的生物发光。弥补了以往质粒标记的生物发光细菌需外加筛选压力和底物,影响发光检测,且单位细胞发光量不稳定等不足之处。荧光酶基因插入染色体中稳定表达,单位细胞的发光数量很稳定。加上生物发光技术极高的特异性和信噪比,即便标记细胞在动物体内有复杂的定位,亦可从动物体表的信号水平直接得出发光细胞的相对数量。可广泛应用于体外细胞感染模型和体内实验动物模型的建立。结合利用活体成像仪器可实时动态的持续监测鼠伤寒沙门菌在小鼠活体内的入侵、增殖及扩散情况。为鼠伤寒沙门菌及伤寒沙门菌致病机制的深入研究,药物研究和筛选及相关疾病防治策略的研究等提供便利的工具。 Beneficial effects: the Salmonella typhimurium has stable bioluminescent performance, which makes up for the defects that the detection of bioluminescent bacteria requires an excitation light source, low specificity in vivo, high background, and difficult quantification. Through site-specific recombination, the housekeeping gene E. coli frr promoter and Lux operon are inserted into the host bacterial chromosome for stable expression (at the same time, the insertion site does not destroy the genome gene function and has no adverse effects on the bacteria). Under the regulation of the housekeeping gene E. coli frr promoter connected upstream, the Lux operon constitutively expresses luciferase and substrates, without additional screening pressure and substrates to maintain bacterial luminescence. And through the experiment, it is detected that the number of bacteria is proportional to its luminous intensity, and the bioluminescence of bacteria can be continuously detected in the living mice. It makes up for the shortcomings of previous plasmid-labeled bioluminescent bacteria that require additional screening pressure and substrates, which affect luminescence detection, and the amount of luminescence per unit cell is unstable. The luciferase gene is inserted into the chromosome and expressed stably, and the luminescent quantity per unit cell is very stable. Coupled with the extremely high specificity and signal-to-noise ratio of bioluminescent technology, even if the labeled cells have complex positioning in the animal body, the relative number of luminescent cells can be directly obtained from the signal level on the animal body surface. It can be widely used in the establishment of in vitro cell infection models and in vivo experimental animal models. Combining the use of in vivo imaging equipment can continuously monitor the invasion, proliferation and spread of Salmonella typhimurium in vivo in real time and dynamically. It provides a convenient tool for in-depth research on the pathogenic mechanism of Salmonella typhimurium and Salmonella typhimurium, drug research and screening, and related disease prevention and control strategies.
the
附图说明 Description of drawings
图1为pBEN276质粒图谱,tnsABCD为编码Tn7转座子的基因。操纵子luxCDABE编码荧光素酶和底物,引入多克隆酶切位点Xho1和Not1,将其连接于Tn7转座子侧翼。Lux操纵子3’端连接E.coli管家基因frr的启动子,启动Lux操纵子的组成性表达。 Figure 1 is a map of the pBEN276 plasmid, and tnsABCD is the gene encoding the Tn7 transposon. The operon luxCDABE , which encodes luciferase and substrate, introduces multiple cloning restriction sites Xho1 and Not1, which are flanked by the Tn7 transposon. The 3' end of the Lux operon is linked to the promoter of the housekeeping gene frr of E. coli to initiate the constitutive expression of the Lux operon.
图2为菌落生物发光检测结果 (1和2依次为Χ3337lux单菌落在whitelight和luminescence条件下成像,3和4依次为Χ3337单菌落在whitelight和luminescence条件下成像)。 Figure 2 shows the results of colony bioluminescence detection (1 and 2 are images of X3337lux single colonies under whitelight and luminescence conditions, and 3 and 4 are images of X3337 single colonies under whitelight and luminescence conditions).
图3为菌液生物发光检测结果(1~5:luminescence模式成像Χ3337lux; 6: luminescence模式成像Χ3337)。 Figure 3 shows the bioluminescence detection results of the bacterial liquid (1~5: luminescence mode imaging Χ3337lux; 6: luminescence mode imaging Χ3337).
图4为Χ3337lux光子量与在无选择压力条件下传代天数的关系图。 Fig. 4 is the graph of the relationship between the amount of Χ3337lux photons and the number of passage days under the condition of no selection pressure.
图5为稳定发光菌在小鼠体内信号检测结果(1,2,3依次为将感染Χ3337lux的小鼠于white light模式成像,luminescence模式成像和merge图像)。 Figure 5 shows the signal detection results of stable luminescent bacteria in mice (1, 2, and 3 are imaging of mice infected with X3337lux in white light mode, luminescence mode imaging and merge image).
图6为光子数与细菌数关系的发光检测图(1~5:10倍稀释Χ3337lux菌液;6:Χ3337阴性对照)。 Figure 6 is a luminescence detection diagram of the relationship between the number of photons and the number of bacteria (1~5: 10-fold dilution of X3337lux bacterial solution; 6: X3337 negative control).
图7为光子数与细菌数关系图(1~5:Χ3337lux菌量倍增;6:Χ3337阴性对照)。 Figure 7 is a diagram of the relationship between the number of photons and the number of bacteria (1~5: Χ3337lux bacterial count doubling; 6: Χ3337 negative control).
the
具体实施方式 Detailed ways
实施例 1Example 1
菌株具体构建及鉴定:Specific construction and identification of strains:
1、材料准备 1. Material preparation
1.1质粒与菌株 1.1 Plasmids and strains
质粒pBEN276由法国自然资源研究所动物传染病和公共健康病原菌研究实验室Pierre Germon教授惠赠。【Kevin Howe, Attila Karsi, Pierre Germon, et.al. Development of stable reporter system cloning luxCDABE genes into chromosome of Salmonella enterica serotypes using Tn7 transposon [J]. BMC Microbiology 2010, 10:197】 Plasmid pBEN276 was kindly donated by Prof. Pierre Germon, Laboratory of Animal Infectious Diseases and Public Health Pathogen Research Laboratory, French Natural Resources Institute. 【Kevin Howe, Attila Karsi, Pierre Germon, et.al. Development of stable reporter system cloning luxCDABE genes into chromosome of Salmonella enterica serotypes using Tn7 transposon [J]. BMC Microbiology 2010, 10:197】
鼠伤寒沙门菌(Salmonella typhimurium) X3337由美国亚利桑那州立大学生物科学学院ROY CURTISS III教授惠赠。【HIDENORI MATSUI, CHRISTOPHER M. BACOT, WENDY A. Virulence Plasmid-Borne spvB and spvC Genes Can Replace the 90-Kilobase Plasmid in Conferring Virulence to Salmonella enterica Serovar Typhimurium in Subcutaneously Inoculated Mice[J]. Journal of bacteriology, 2001,15(183): 4652–4658.】 Salmonella typhimurium ( Salmonella typhimurium ) X3337 was kindly provided by Professor ROY CURTISS III, College of Biological Sciences, Arizona State University, USA. [HIDENORI MATSUI, CHRISTOPHER M. BACOT, WENDY A. Virulence Plasmid-Borne spvB and spvC Genes Can Replace the 90-Kilobase Plasmid in Conferring Virulence to Salmonella enterica Serovar Typhimurium in Subcutaneously Inoculated Mice[J]. Journal of bacteriology1, 15001 (183): 4652–4658.]
1.2 仪器与试剂 1.2 Instruments and reagents
仪器:电转仪(Bio-RadGene Pulser II system)为美国Bio-Rad产品; Instrument: Electrotransfer instrument (Bio-RadGene Pulser II system) is a product of American Bio-Rad;
高速冷冻离心机Beckaman公司产品; High-speed refrigerated centrifuge Beckaman products;
柯达多模式小动物活体成像系统DXS4000pro; Kodak multi-mode small animal live imaging system DXS4000pro;
试剂:质粒提取试剂盒QIAGEN Plasmid MaxKit购自Qiagen 公司。 Reagents: Plasmid extraction kit QIAGEN Plasmid MaxKit was purchased from Qiagen.
2 方法 2 methods
2.1目的菌株的转化 2.1 Transformation of the target strain
2.1.1感受态细胞制备:平板划线法接种鼠伤寒沙门菌X3337至LB固体培养基,37℃倒置培养过夜。挑取个体圆润有光泽的单菌落接种到3mL LB液体培养基,37℃,200r/min培养过夜。将培养物以1:100的比例接种到100mL生长培养基中,37℃,250r/min培养至OD600为0.3时取出培养物,立即冰浴30min。4℃,4000r/min离心10min,收集菌体。用4℃预冷的超纯水洗三遍,以50μL预冷的超纯水重悬,冰上放置待用。 2.1.1 Competent cell preparation: Inoculate Salmonella typhimurium X3337 into LB solid medium by streaking method on a plate, and incubate overnight at 37°C. Pick individual round and glossy single colonies and inoculate them into 3mL LB liquid medium, and culture overnight at 37°C and 200r/min. The culture was inoculated into 100 mL of growth medium at a ratio of 1:100, cultured at 37°C and 250 r/min until the OD600 was 0.3, the culture was taken out, and immediately placed in an ice bath for 30 min. Centrifuge at 4000r/min for 10min at 4°C to collect the cells. Wash three times with 4°C pre-cooled ultrapure water, resuspend in 50 μL pre-cooled ultra-pure water, and place on ice until use.
2.1.2电转化方案:将质粒pBEN276加入到50μL感受态细胞中,混合均匀后转入预冷的1mm电极杯。再调节电压、电阻及电容参数为2.5kV,400Ω,50μF,电击后迅速加入30℃预热的SOC培养基1mL。将电击后的菌液转移至试管,37℃,100r/min培养1~3h。取100 μL涂布于含40μg/mL氨苄青霉素的LB平板上,37℃培养过夜。 2.1.2 Electroporation scheme: Add the plasmid pBEN276 into 50 μL of competent cells, mix well and transfer to a pre-cooled 1 mm electrode cup. Then adjust the voltage, resistance and capacitance parameters to 2.5kV, 400Ω, 50μF, and quickly add 1mL of SOC medium preheated at 30°C after the electric shock. Transfer the electroshocked bacterial solution to a test tube, and incubate at 37°C, 100r/min for 1-3h. 100 μL was spread on LB plates containing 40 μg/mL ampicillin, and incubated overnight at 37°C.
2. 2转化子鉴定 2.2 Identification of transformants
阳性克隆从含50μg/mL Amp的LB琼脂平板上挑出接种至2mL含50μg/mL Amp液体LB培养基30℃,200rpm培养14~16h,将菌液转移至24孔板检测生物发光。同时提取质粒进行酶切鉴定和PCR鉴定,并接种于SS固体培养基进行鼠伤寒沙门菌生化鉴定。 Positive clones were picked from the LB agar plate containing 50 μg/mL Amp and inoculated into 2 mL liquid LB medium containing 50 μg/mL Amp at 30°C and 200 rpm for 14-16 hours, and the bacterial liquid was transferred to a 24-well plate to detect bioluminescence. At the same time, the plasmid was extracted for enzyme digestion and PCR identification, and inoculated on SS solid medium for biochemical identification of Salmonella typhimurium.
2.3诱导转座子重组 2.3 Induction of transposon recombination
将上述经鉴定的转化子接种至含0.1%wt阿拉伯糖的LB液体培养基30℃,200rpm培养14~16h。诱导后的菌液于无抗生素LB固体培养基平板上划线,42℃培养14~16h。各挑选6个单克隆接种于液体LB培养基42℃,200rpm培养14~16h,菌液转移至24孔板检测生物发光。 The above-identified transformants were inoculated into LB liquid medium containing 0.1%wt arabinose at 30°C and cultured at 200rpm for 14-16h. The induced bacterial solution was streaked on the LB solid medium plate without antibiotics, and cultured at 42°C for 14-16h. Each selected 6 single clones were inoculated in liquid LB medium at 42°C, cultured at 200rpm for 14-16h, and the bacterial solution was transferred to a 24-well plate to detect bioluminescence.
2.4筛选稳定表达Lux操纵子的克隆 2.4 Screening for clones stably expressing the Lux operon
挑选出重组后能发光的菌液于含50μg/mL Amp固体LB培养基上划线,同时在无抗生素培养基中继续传代37℃培养,定量检测细菌发光情况。筛选出无抗生素抗性且多次传代能稳定发光的菌落。 The bacterial solution capable of luminescence after recombination was selected and streaked on the solid LB medium containing 50 μg/mL Amp, and at the same time continued to subculture in the antibiotic-free medium and cultured at 37°C to quantitatively detect the luminescence of the bacteria. Colonies without antibiotic resistance and stable luminescence after multiple passages were screened.
the
菌株的培养增殖方法:Bacterial strain culture propagation method:
Χ3337lux为兼性厌氧菌,在普通LB培养基中可生长,培养基成分:蛋白胨10g,酵母提取物5g,NaCl 10g,溶于1L水,pH=7±0.2,培养温度37℃条件可稳定增殖。新菌种Χ3337lux区别于Χ3337的是具有稳定的生物发光性能。Lux操纵子位点特异性插入染色体,对细菌的其他生理特性无影响。 Χ3337lux is a facultative anaerobic bacterium that can grow in ordinary LB medium. Medium ingredients: peptone 10g, yeast extract 5g, NaCl 10g, dissolved in 1L water, pH=7±0.2, culture temperature 37 ℃ conditions can be stable proliferation. The difference between the new strain Χ3337lux and Χ3337 is that it has stable bioluminescent properties. The Lux operon site-specific insertion into the chromosome has no effect on other physiological characteristics of bacteria.
the
菌种形态与生化特性检测: Species morphology and biochemical characteristics detection:
液体LB培养基37℃培养过夜细菌均匀浑浊。取一环菌液适当稀释后革兰染色镜检,该菌为革兰阴性杆菌。用固体LB培养基37℃培养18h,形成乳白色菌落,表面光滑,边缘整齐,直径1~3mm。SS培养基37℃培养18~24h上菌落形态为中等大小、圆形、光滑、乳白色、菌落中心黑色,硫化氢阳性。挑取单菌落接种于生化管37℃培养过夜,检测生化特性,该菌不发酵乳糖和蔗糖,能发酵葡萄糖、甘露醇、麦芽糖。挑取单菌落接种于半固体琼脂,37℃培养18~24h ,细菌呈羽毛状生长,动力阳性。 The liquid LB medium was cultivated overnight at 37°C and the bacteria were uniformly turbid. Take a ring of bacterial solution and dilute it properly, then check it with Gram staining microscope, the bacteria are Gram-negative bacilli. Cultivate with solid LB medium at 37°C for 18 hours to form a milky white colony with a smooth surface, neat edges, and a diameter of 1-3mm. The SS medium was cultured at 37°C for 18-24 hours, and the colony morphology was medium-sized, round, smooth, milky white, with a black center of the colony, and positive for hydrogen sulfide. Pick a single colony and inoculate it in a biochemical tube for overnight cultivation at 37°C to test its biochemical characteristics. The bacteria do not ferment lactose and sucrose, but can ferment glucose, mannitol, and maltose. Pick a single colony and inoculate it on semi-solid agar, culture at 37°C for 18-24 hours, the bacteria grow in a feathery shape, and the motility is positive.
the
菌落生物发光检测: Colony bioluminescence detection:
分区划线法将Χ3337lux接种于LB平板,37℃,培养14~16h。待长出单菌落后,将平板置于多模式活体成像仪中进行生物发光检测。在生物发光检测模式下,可见发光菌单菌落(Χ3337lux),而普通细菌单菌落(Χ3337)不可见(图2)。 Inoculate Χ3337lux on LB plates by the method of partitioning and streaking, culture at 37°C for 14-16 hours. After a single colony grows, the plate is placed in a multi-mode in vivo imager for bioluminescence detection. In the bioluminescence detection mode, a single colony of luminescent bacteria (Χ3337lux) was visible, but a single colony of common bacteria (Χ3337) was invisible (Figure 2).
the
菌液生物发光检测及稳定性检测: Bacterial liquid bioluminescence detection and stability detection:
Χ3337lux单菌落接种至液体LB培养基37℃,200rpm培养14~16h,菌液转移至24孔板检测生物发光。生物发光模式下只可见发光菌(Χ3337lux),普通细菌(Χ3337)不可见(图3)。在无选择压力条件下传代培养,每天收集菌液OD600稀释至等体积等浓度菌液进行生物发光检测,记录光子量,Χ3337lux发光性能稳定(图4)。 A single colony of Χ3337lux was inoculated into liquid LB medium at 37°C, cultured at 200rpm for 14-16h, and the bacterial solution was transferred to a 24-well plate to detect bioluminescence. In the bioluminescence mode, only luminescent bacteria (Χ3337lux) were visible, and common bacteria (Χ3337) were invisible (Figure 3). Subculture under the condition of no selection pressure, collect the OD 600 of the bacterial liquid every day and dilute it to an equal volume and concentration of the bacterial liquid for bioluminescence detection, record the amount of photons, and the luminescence performance of Χ3337lux is stable (Figure 4).
the
实施例 2Example 2
鼠伤寒沙门菌(Salmonella typhimurium)Χ3337lux活体成像 Salmonella typhimurium ( Salmonella typhimurium ) Χ3337lux live imaging
1.细菌培养 1. Bacterial culture
从固体LB琼脂平板上挑选单克隆接种至LB液体培养基中,37℃,200rpm培养14~16h至对数生长期。4000rpm,4℃,10min离心收集菌体,经生理盐水洗两遍(4000rpm,4℃,10min)后,用生理盐水重悬,测OD600 计算细菌浓度。用生理盐水梯度稀释待用。 Select a single clone from the solid LB agar plate and inoculate it into LB liquid medium, and culture at 37°C, 200rpm for 14-16h to logarithmic growth phase. Collect bacteria by centrifugation at 4000rpm, 4°C, 10min, wash twice with normal saline (4000rpm, 4°C, 10min), resuspend with normal saline, measure OD600 to calculate the bacterial concentration. Gradiently diluted with normal saline for use.
2.小鼠感染方法(腹腔注射或口饲感染) 2. Mice infection method (intraperitoneal injection or oral feeding infection)
2.1腹腔注射感染 2.1 Intraperitoneal injection infection
选取8-12周BALB/C或C57BL小鼠,以50μL浓度105CFU/mL的菌液腹腔注射感染小鼠。 BALB/C or C57BL mice of 8-12 weeks were selected, and 50 μL of bacterial solution with a concentration of 10 5 CFU/mL was injected intraperitoneally to infect the mice.
2.2.口饲感染 2.2. Oral feeding infection
8-12周BALB/C或C57BL小鼠禁食禁水6h后,以50μL 10%wt的NaHCO3灌胃,中和胃酸,以体积0.2 mL浓度107CFU/mL的菌液灌胃感染小鼠,半小时后恢复喂食。 After 8-12 weeks of fasting, BALB/C or C57BL mice were fasted for 6 hours, and were given 50 μL of 10 % wt NaHCO 3 to neutralize gastric acid. Rats, resume feeding after half an hour.
3.活体成像方法 3. In vivo imaging method
以10%wt水合氯醛0.1mL经腹腔注射麻醉小鼠,待麻醉生效(约30min)后利用小动物成像仪成像。首先在白光(white light)条件下成像,只可见小鼠。然后在生物发光(luminescence)条件下成像,只可见发光菌。将两次成像结果归并(merge),可见发光菌感染后播散到的部位(图5)。经光子量分析可计算发光菌在体内的增殖情况(图6,7)。 The mice were anesthetized by intraperitoneal injection of 0.1 mL of 10%wt chloral hydrate, and imaged with a small animal imager after the anesthesia took effect (about 30 min). First imaged under white light conditions, only mice were visible. Then imaged under luminescence conditions, only the luminescent bacteria were visible. The two imaging results were merged, and the site where the luminescent bacteria spread after infection could be seen (Figure 5). The proliferation of luminescent bacteria in vivo can be calculated by photon analysis (Figure 6, 7).
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012102062501A CN102757912A (en) | 2012-06-21 | 2012-06-21 | Salmonella typhimurium X3337lux and applications of salmonella typhimurium X3337lux in living body imaging |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012102062501A CN102757912A (en) | 2012-06-21 | 2012-06-21 | Salmonella typhimurium X3337lux and applications of salmonella typhimurium X3337lux in living body imaging |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102757912A true CN102757912A (en) | 2012-10-31 |
Family
ID=47052564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012102062501A Pending CN102757912A (en) | 2012-06-21 | 2012-06-21 | Salmonella typhimurium X3337lux and applications of salmonella typhimurium X3337lux in living body imaging |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102757912A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1448504A (en) * | 2003-05-07 | 2003-10-15 | 华东师范大学 | Construction and application of engineering bacterium LZ-17 |
EP2166083A1 (en) * | 2008-12-31 | 2010-03-24 | Syngen biotech CO., LTD. | Novel Lactobacillus paracasei subsp. paracasei SG96, a bacteriostatic composition containing the same and use thereof |
-
2012
- 2012-06-21 CN CN2012102062501A patent/CN102757912A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1448504A (en) * | 2003-05-07 | 2003-10-15 | 华东师范大学 | Construction and application of engineering bacterium LZ-17 |
EP2166083A1 (en) * | 2008-12-31 | 2010-03-24 | Syngen biotech CO., LTD. | Novel Lactobacillus paracasei subsp. paracasei SG96, a bacteriostatic composition containing the same and use thereof |
Non-Patent Citations (2)
Title |
---|
KEVIN HOWE ET AL.: "Development of stable reporter system cloning luxCDABE genes into chromosome of Salmonella enterica serotypes using Tn7 transposon", 《BMC MICROBIOLOGY》 * |
VIRULENCE PLASMID-BORNE SPVB AND SPVC GENES CAN REPLACE THE 90-K: "Virulence Plasmid-Borne spvB and spvC Genes Can Replace the 90-Kilobase Plasmid in Conferring Virulence to Salmonella enterica Serovar Typhimurium in Subcutaneously Inoculated Mice", 《JOURNAL OF BACTERIOLOGY》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Min et al. | Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals | |
Votyakova et al. | Influence of viable cells on the resuscitation of dormant cells in Micrococcus luteus cultures held in an extended stationary phase: the population effect | |
CN109810931A (en) | A kind of culture medium and its application method for cultivating thermophilic mucin Ackermam Salmonella | |
CN116286557B (en) | Salt-tolerant bacillus beijerinckii for producing cellulase and culture method thereof | |
Yang et al. | Novibacillus thermophilus gen. nov., sp. nov., a Gram-staining-negative and moderately thermophilic member of the family Thermoactinomycetaceae | |
Bhattacharya et al. | Isolation and characterization of Rhizobium sp. form root of legume plant (Pisum sativum) and its antibacterial activity against different bacterial strains | |
CN102757910A (en) | Mouse typhus salmonella UF110lux and application of mouse typhus salmonella UF110lux in living body imaging | |
Qin et al. | A SacB-based system for diverse and multiple genome editing in Gluconobacter oxydans | |
CN116083275B (en) | Salmonella Indiana and its application | |
CN116904332B (en) | Propionibacterium acnes with good antioxidant effect and application thereof | |
Pandey et al. | Organic metabolites produced by Vibrio parahaemolyticus strain An3 isolated from Goan mullet inhibit bacterial fish pathogens | |
CN102757911A (en) | Salmonella typhimurium X3306lux and applications of salmonella typhimurium X3306lux in living body imaging | |
Gutiérrez et al. | Halorubrum kocurii sp. nov., an archaeon isolated from a saline lake | |
CN102807961B (en) | A kind of Streptococcus suis type 7 high-density fermentation medium and special strain | |
CN102757912A (en) | Salmonella typhimurium X3337lux and applications of salmonella typhimurium X3337lux in living body imaging | |
CN103352012A (en) | Salmonella typhimurium X3337-pRST98lux and its application in live imaging | |
CN104471054A (en) | Production and Application of Protozoa Histomonas turkey (H.MELEAGRIDIS) Culture | |
CN110129349B (en) | Method for constructing fluorescent-expressing suicide plasmid and strain based on ISApl1 insertion sequence | |
KR101773580B1 (en) | Novel Salmonella for treatment of cancer, and use thereof | |
Abrams et al. | Genomic characteristics of an environmental microbial community harboring a novel human uncultured TM7 bacterium associated with oral diseases | |
Ibrahim et al. | Optimizing arginine deiminase production from Pseudomonas aeruginosa clinical isolate | |
Ma et al. | Biochemical characterization of a recombinant Lactobacillus acidophilus strain expressing exogenous FomA protein | |
Zhang et al. | Hoeflea poritis sp. nov., isolated from a bleached scleractinian coral Porites lutea | |
Li et al. | Parabacteroides pekinense sp. nov.: a new bacterium isolated from the stool of a healthy man living in China | |
RU2769790C1 (en) | Set of recombinant fluorescent strains of yersinia pestis bacteria of main subspecies biovar and the altai biovar of the central asiatic subspecies for indication of plague agent in experimental samples |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20121031 |